Physician

Matthew Armstrong Powers, MD, MBA

According to 2025 Medicare claims, Matthew Powers, MD, MBA (NPI: 1295152379) practices ophthalmology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. Powers uses personal NPI as billing NPI and primary practice location at 95403-3612.

Powers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 969 traditional Medicare patients, billed 71,486 HCPCS/CPT codes, and received $4,229,595 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 436 prescription claims across 142 beneficiaries totaling $21,075 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 1 records totaling $34. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $22,936 to $4,229,595. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2018 Medicare payment: $22,936 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $54,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $878,608 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,701,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,234,552 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,868,739 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,229,595 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018309490$22,936
2019406937$54,210
20205993,235$878,608
20217788,984$2,701,986
202288117,098$3,234,552
202387851,869$3,868,739
202496971,486$4,229,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$43K2015 Drug cost: $1,819 (USD; Tot_Drug_Cst)2018 Drug cost: $6,979 (USD; Tot_Drug_Cst)2019 Drug cost: $9,717 (USD; Tot_Drug_Cst)2020 Drug cost: $19,332 (USD; Tot_Drug_Cst)2021 Drug cost: $42,863 (USD; Tot_Drug_Cst)2022 Drug cost: $30,928 (USD; Tot_Drug_Cst)2023 Drug cost: $25,872 (USD; Tot_Drug_Cst)2024 Drug cost: $21,075 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151243$1,819
2016N/RN/RN/R
2017N/RN/RN/R
201842114$6,979
201989203$9,717
2020103267$19,332
2021144477$42,863
2022116404$30,928
2023148459$25,872
2024142436$21,075

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2291,972$659
67028Injection of drug into eye4141,865$110
92014Established patient complete exam of visual system526616$100
92134Imaging of retina9552,775$34
J2777Injection, faricimab-svoa, 0.1 mg20058,020$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium15665$5,292
Prednisolone AcetatePrednisolone Acetate1153,975$4,301
Bromfenac SodiumBromfenac Sodium18743$3,162
Brimonidine TartrateBrimonidine Tartrate452,493$1,452
OfloxacinOfloxacin852,035$863

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$34Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Armstrong Powers, MD, MBA?

Tedicare shows public-source Medicare data for Matthew Armstrong Powers, MD, MBA (NPI 1295152379), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Armstrong Powers, MD, MBA have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Armstrong Powers, MD, MBA?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Matthew Armstrong Powers, MD, MBA have Open Payments data?

Matthew Armstrong Powers, MD, MBA has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.